Table 5.
Subpathway | Biochemical Name | Groups | |||
---|---|---|---|---|---|
Infertility vs Spontaneous | IVF vs Spontaneous | NIFT vs Spontaneous | IVF vs NIFT | ||
Xanthine metabolism | Paraxanthine | 0.59a | 0.53a | 0.72 | 0.74 |
Xanthine metabolism | 1,3,7-Trimethylurate | 0.57a | 0.55a | 0.63b | 0.86 |
Xanthine metabolism | 1-Methylxanthine | 0.59a | 0.54a | 0.70 | 0.77 |
Xanthine metabolism | 5-Acetylamino-6-formylamino-3-methyluracil | 0.54a | 0.48a | 0.66 | 0.73 |
Drug (analgesics, anesthetics) | Salicyluric glucuronide | 1.72c | 1.96c | 1.24 | 1.58 |
Benzoate metabolism | 2-Hydroxyhippurate (salicylurate) | 1.71c | 1.98c | 1.16 | 1.72 |
Benzoate metabolism | 3-Hydroxyhippurate | 1.69d | 2.06c | 0.95 | 2.18c |
Benzoate metabolism | 4-Hydroxyhippurate | 1.34 | 1.53c | 0.96 | 1.59c |
Benzoate metabolism | 3-(3-Hydroxyphenyl) propionate sulfate | 1.47c | 1.66c | 1.09 | 1.51d |
In the metabolome cohort, fold changes of members from subpathways of xanthine metabolism and benzoate metabolism are shown between the following groups: infertility vs spontaneous, the IVF vs spontaneous, NIFT vs spontaneous, and IVF vs NIFT. Analysis of covariance was performed, using BMI as a covariate.
P < 0.05 for decreased levels of metabolites.
0.05 < P < 0.1 for decreased levels of metabolites.
P < 0.05 for increased levels of metabolites.
0.05 < P < 0.1 for increased levels of metabolites.